AOD 9604: The Ultimate Guide to Fat Loss, Tissue Repair, and Metabolic Health
A 7-minute clinician-style training overview of AOD 9604 covering its proposed mechanism, uses, dosing ranges, lab monitoring and three case studies, ending with a course promotion.
With Dr. Adam Sewell (MD)
Key moments
Tap a moment to play the video from there.
- 0:00Session overview and what AOD 9604 isSewell outlines the topics for the session and introduces AOD 9604 as a modified fragment of human growth hormone, amino acids 176 to 191.
- 0:29Mechanism of action explainedHe says the peptide mimics the fat-burning region of growth hormone without acting on its receptors. He adds that it does not significantly affect blood sugar or insulin.
- 2:01Clinical applications listedSewell lists weight and fat reduction, metabolic syndrome, joint repair, post-surgical recovery, body composition and anti-aging as uses.
- 2:47Benefits, risks and alternativesHe describes mild side effects and notes that long-term human data is limited. He then names alternatives for fat loss and tissue repair.
- 4:09Dosing protocols by goalHe gives subcutaneous daily ranges for fat reduction, tissue repair and post-surgical recovery. He says protocols run 4 to 12 weeks.
- 4:53Recommended laboratory evaluationsSewell recommends a metabolic panel, lipid profile, body composition and inflammation markers at baseline. He suggests repeat assessments afterward and imaging for repair cases.
- 5:39Case studies: fat loss and kneeHe presents a 45-year-old man with metabolic syndrome and a 55-year-old woman with knee osteoarthritis, and reports improvements in both.
- 6:40ACL recovery case studySewell describes a 30-year-old athlete after ACL reconstruction who used the peptide for 6 weeks. He reports faster recovery of range of motion and strength.
- 7:03Conclusion and course promotionHe calls the peptide a versatile option with proper patient selection and monitoring, then promotes a free peptide certification course.
What the video says
This is a short training-style presentation from Dr. Adam Sewell, who describes AOD 9604 as a peptide with potential in fat metabolism and tissue repair. It is a single-speaker walkthrough, not a discussion or interview, and it ends with a promotion for a free peptide certification course run by the channel.
Sewell says AOD 9604 is a modified fragment of human growth hormone, amino acids 176 to 191, designed to keep the fat-reducing properties without growth hormone's effects on glucose or cell proliferation. He says it works by encouraging fat breakdown and discouraging new fat formation, particularly in abdominal stores. He also says it may support cartilage and musculoskeletal repair by promoting cell growth and reducing inflammation. The applications he lists are weight and fat reduction, metabolic syndrome, joint and cartilage repair, post-surgical recovery, body composition and anti-aging.
On safety, Sewell describes the peptide as generally well tolerated, with mild headache, nausea or fatigue and occasional injection site redness or swelling. He also mentions hypothetical risks because long-term human studies are limited. He names alternatives such as L-carnitine, lipotropic injections, semaglutide, PRP, hyaluronic acid and other peptides, but does not discuss them in detail. His dosing ranges are 200 to 300 micrograms subcutaneously per day for fat reduction, 250 to 500 micrograms daily or every other day for tissue repair, and 300 to 500 micrograms daily for 4 to 6 weeks after surgery, with protocols of 4 to 12 weeks overall. He recommends baseline and follow-up labs, including a metabolic panel, lipid profile, inflammation markers and imaging for repair cases.
The last third presents three clinical cases: a 45-year-old man with metabolic syndrome, a 55-year-old woman with knee osteoarthritis, and a 30-year-old athlete after ACL reconstruction. Sewell reports favorable outcomes in each. The cases are summarized in one or two sentences apiece with no comparison groups, so they read as illustrations rather than evidence.
On each compound
AOD-96040:29
Sewell describes it as a modified growth hormone fragment, amino acids 176 to 191, that he says promotes fat breakdown and may support cartilage and tissue repair without systemic hormonal effects. He gives dose ranges of 200 to 500 micrograms subcutaneously per day and calls it generally well tolerated.
See how your DNA reads AOD-9604What this video doesn’t settle
- The video cites no studies, trial data or references for its claims about fat loss, cartilage regeneration or recovery.
- The three case studies have no control groups, and it is unclear whether they are real patients, composites or illustrations.
- Sewell acknowledges limited long-term human data, so the safety of extended use is not established here.
Questions this video answers
What is AOD 9604 according to Dr. Adam Sewell?
Sewell says it is a modified fragment of human growth hormone, amino acids 176 to 191. He says it was designed to keep the fat-reducing properties of growth hormone without effects on glucose metabolism or cell proliferation.
What AOD 9604 doses does the video mention?
Sewell gives 200 to 300 micrograms subcutaneously daily for fat reduction and 250 to 500 micrograms daily or every other day for tissue repair. For post-surgical recovery he gives 300 to 500 micrograms daily for 4 to 6 weeks, and he says overall protocols run 4 to 12 weeks.
What side effects of AOD 9604 does Sewell describe?
He says it is generally well tolerated, with mild headache, nausea or fatigue and rare injection site redness or swelling. He says these typically resolve without intervention and adds that there are hypothetical risks because long-term human studies are limited.
What lab tests does the video recommend with AOD 9604?
Sewell recommends a comprehensive metabolic panel, lipid profile, body composition measurements and inflammation markers such as CRP and ESR at baseline. He suggests periodic weight and body fat checks during treatment, repeat assessments afterward, and MRI or ultrasound for cartilage or tissue repair cases.
What case studies does the AOD 9604 video present?
Sewell presents three cases: a 45-year-old man with metabolic syndrome, a 55-year-old woman with knee osteoarthritis, and a 30-year-old athlete after ACL reconstruction. He reports improved outcomes in each, using doses of 300, 400 and 500 micrograms daily.
Video by Dr. Adam Sewell, M.D. | Medical Entrepreneur on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
